Recombinate study.
作者信息
Gomperts E
机构信息
Baxter Healthcare Corporation, Hyland Division, Glendale, CA 91203.
出版信息
Ann Hematol. 1994;68 Suppl 3:S51. doi: 10.1007/BF01774533.
PMID:7910040
Abstract
摘要
相似文献
1
Recombinate study.重组研究。
Ann Hematol. 1994;68 Suppl 3:S51. doi: 10.1007/BF01774533.
2
A 3.5-year study of immune function in persons with hemophilia infusing recombinant factor VIII.一项针对输注重组凝血因子VIII的血友病患者免疫功能的3.5年研究。
Ann Hematol. 1994;68 Suppl 3:S49-50. doi: 10.1007/BF01774532.
3
Changes in CD4 count relative to product usage: findings from the transfusion safety study.
Semin Hematol. 1993 Oct;30(4 Suppl 5):7-9.
4
Hemofil-M study.Hemofil-M研究。
Ann Hematol. 1994;68 Suppl 3:S55-7. doi: 10.1007/BF01774535.
5
6
Current status of clinical studies of recombinant factor VIII (recombinate) in patients with hemophilia A. Recombinate Study Group.
Transfus Med Rev. 1992 Oct;6(4):252-5. doi: 10.1016/s0887-7963(92)70176-x.
7
Beriate-P study.贝里亚特-P研究
Ann Hematol. 1994;68 Suppl 3:S53-4. doi: 10.1007/BF01774534.
8
9
Monoclate-P--hemofil-M study.
Ann Hematol. 1994;68 Suppl 3:S45-7. doi: 10.1007/BF01774531.
10
引用本文的文献
1
Blood safety and the choice of anti-hemophilic factor concentrate.血液安全与抗血友病因子浓缩物的选择
Pediatr Blood Cancer. 2006 Sep;47(3):245-54. doi: 10.1002/pbc.20895.
Zotero 插件